Business
Jaguar Health to Hold Investor Webcast Thursday, August 14 at 8:30 AM Eastern Regarding Q2 2025 Financials & Corporate Updates
Click here to register Company plans to file its Earnings Report on August 14, 2025 on Form 10-Q for the quarter ended June 30, 2025 Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; ...
About this update from Jaguar Health, Inc.
[{"type":"text","content":"Click here to register","length":22,"tagName":"p"},{"type":"text","content":"Company plans to file its Earnings Report on August 14, 2025 on Form 10-Q for the quarter ended June 30, 2025","length":109,"tagName":"p"},{"type":"text","content":"Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to register","length":138,"tagName":"p"},{"type":"text","content":"SAN FRANCISCO, CALIFORNIA / ACCESS Newswire / August 12, 2025 / Jaguar Health, Inc. (NASDAQ:JAGX) today announced that the company will conduct an investor webcast on Thursday, August 14, 2025, at 8:30 a.m. Eastern to review second-quarter 2025 financials and provide corporate updates.","length":286,"tagName":"p"},{"type":"text","content":"Participation Instructions for Jaguar Investor Webcast","length":54,"tagName":"p","attribs":{}},{"type":"text","content":"When: Thursday, August 14, 2025 at 8:30 AM Eastern Time","length":55,"tagName":"p","attribs":{}},{"type":"text","content":"Participant Registration & Access Link: Click Here","length":54,"tagName":"p","attribs":{}},{"type":"text","content":"Participation Instructions for Jaguar's Virtual Presentation at the Emerging Growth Conference","length":98,"tagName":"p","attribs":{}},{"type":"text","content":"When: Wednesday, August 20, 2025 from 2:55 - 3:05 PM Eastern Time","length":65,"tagName":"p","attribs":{}},{"type":"text","content":"Where: Online (Click Here)","length":26,"tagName":"p","attribs":{}},{"type":"text","content":"Registration link for conference: Click Here","length":44,"tagName":"p","attribs":{}},{"type":"text","content":"Replay: An archived webcast of the presentation will be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel.","length":136,"tagName":"p","attribs":{}},{"type":"text","content":"About the Jaguar Health Family of Companies","length":43,"tagName":"p"},{"type":"text","content":"Jaguar Health, Inc. (Jaguar) is a commercial stage pharmaceuticals company focused on developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for people and animals with gastrointestinal distress, specifically associated with overactive bowel, which includes symptoms such as chronic debilitating diarrhea, urgency, bowel incontinence, and cramping pain. Jaguar famil...